Study #2025-0277
Phase II trial of Ivonescimab in previously treated patients with advanced clear cell renal cell carcinoma
MD Anderson Study Status
Enrolling
Treatment Agent
Ivonescimab
Description
To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ccRCC.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Ivonescimab, Clear Cell Renal Carcinoma
Study phase:
Phase II
Physician name:
Pavlos Msaouel
Department:
Genitourinary Medical Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.